Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Chest

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/chest.08-0608PMID 18641106PMCID PMC5104558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of Osteoporosis in Adults with Cystic Fibrosis

  2012cited by this paper
• Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Randomized Trial

  2008cited by this paper
• Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis

  2007cited by this paper
• Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

  2007cited by this paper
• Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density

  2007cited by this paper
• Cystic fibrosis: a review of epidemiology and pathobiology.

  2007cited by this paper
• Update on maintaining bone health in cystic fibrosis

  2006cited by this paper
• Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

  2006cited by this paper
• Bisphosphonates

  2006cited by this paper
• Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.

  2006cited by this paper
• Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis.

  2006cited by this paper
• Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.

  2006cited by this paper
• Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

  2006cited by this paper
• Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women

  2005cited by this paper
• Consensus statement: Guide to bone health and disease in cystic fibrosis

  2005cited by this paper
• Oral bisphosphonates improve Bone Mineral Density in adults with cystic fibrosis.

  2005cited by this paper
• Efficacy of alendronate in adults with cystic fibrosis with low bone density.

  2004cited by this paper
• [Effect of oral biphosphonates in patients with cystic fibrosis and low bone mineral density].

  2004cited by this paper
• Bone mineral density thresholds for pharmacological intervention to prevent fractures.

  2004cited by this paper
• Treatment With Once‐Weekly Alendronate 70 mg Compared With Once‐Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double‐Blind Study

  2004cited by this paper
• Inflammatory related changes in bone mineral content in adults with cystic fibrosis

  2004cited by this paper
• Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study

  2004cited by this paper
• Efficacité des biphosphonates oraux sur la déminéralisation osseuse des patients atteints de mucoviscidose

  2004cited by this paper
• Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada

  2003cited by this paper
• Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis

  2001cited by this paper
• Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.

  2000cited by this paper
• Vertebral fractures in osteoporosis: a new method for clinical assessment.

  2000cited by this paper
• Bone loss and fracture after lung transplantation.

  1999cited by this paper
• Lung transplantation in cystic fibrosis: consensus conference statement.

  1998cited by this paper
• Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis.

  1998cited by this paper
• International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

  1998cited by this paper
• Development of formulas for standardized DXA measurements

  1995cited by this paper
• Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results.

  1995cited by this paper

• Menopause in Cystic Fibrosis: Special considerations for bone health, menopausal symptoms, and treatment.

  2025cites this paper
• Nanofiber-Based Platforms for Osteoarthritis: Advances in Drug Delivery with Cartilage & Bone Tissue Regeneration

  2025cites this paper
• Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment

  2025cites this paper
• Bisphosphonates for osteoporosis in people with cystic fibrosis.

  2023cites this paper
• Bone fragility and osteoporosis in children and young adults

  2023cites this paper
• Romosozumab used to treat a patient with cystic fibrosis-related osteoporosis.

  2022cites this paper
• Treatment of cystic fibrosis related bone disease

  2021cites this paper
• Effects of Digestive Diseases on Bone Metabolism

  2021cites this paper
• Cystic Fibrosis-Related Bone Disease: Current Knowledge and Future Directions

  2020cites this paper
• Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose.

  2019cites this paper
• Endocrine Complications of Cystic Fibrosis: A Multisystem Disease of the Endocrine Organs

  2019cites this paper
• Cystic fibrosis bone disease treatment: Current knowledge and future directions.

  2019cites this paper
• Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians.

  2017influential citation
• Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis

  2016cites this paper
• Osteoporoza w mukowiscydozie/ Osteoporosis in cystic fibrosis

  2015cites this paper
• The Role of Nutrition for Bone Health in Cystic Fibrosis

  2015cites this paper
• Bisphosphonates for osteoporosis in people with cystic fibrosis.

  2014cites this paper
• A Review of Osteoporosis Management in Younger Premenopausal Women

  2014cites this paper
• Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate.

  2013cites this paper
• Recognizing and treating secondary osteoporosis

  2012cites this paper
• Bisphosphonates for osteoporosis in people with cystic fibrosis.

  2012cites this paper
• Osteoporosis in young adults: pathophysiology, diagnosis, and management

  2012cites this paper
• Wasting Diseases and Metabolic Impact on Bone: Emerging Therapeutics and Treatment Options

  2012cites this paper
• Остеопороз у больных муковисцидозом: новая проблема и нерешенные вопросы

  2011cites this paper
• Treatment options for cystic fibrosis: state of the art and future perspectives.

  2011cites this paper
• Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis.

  2011cites this paper
• Adults with Cystic Fibrosis

  2011cites this paper
• Geneesmiddelen ter preventie van osteoporosische fracturen

  2011cites this paper
• Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial)

  2010cites this paper
• Impact of cystic fibrosis on bone health

  2010cites this paper
• Bone mineral density in lung transplant candidates.

  2010cites this paper
• Treatment of osteoporosis after liver transplantation with ibandronate

  2010cites this paper
• A Roadmap to the Brittle Bones of Cystic Fibrosis

  2010cites this paper
• The Prevalence of Osteoporosis, Osteopenia, and Fractures Among Adults with Cystic Fibrosis: A Systematic Literature Review with Meta-Analysis

  2009cites this paper
• Diabetes mellitus and bone disease in cystic fibrosis.

  2009cites this paper
• Diabetes Mellitus and Bone Disease in Cystic Fibrosis

  2009cites this paper
• Update on cystic fibrosis-related bone disease: a special focus on children.

  2009cites this paper
• The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study

  2009cites this paper
• ‘Old’ bones in young bodies: the tale of cystic fibrosis

  2009cites this paper
• Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients

  2008cites this paper
• Bmc Musculoskeletal Disorders Longitudinal Analysis of Vertebral Fracture and Bmd in a Canadian Cohort of Adult Cystic Fibrosis Patients

  2008cites this paper